Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cholangiocarcinoma × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 12 Neoplasms 4 Colorectal Neoplasms 3 Adenocarcinoma 3 Pancreatic Cancer Metastatic 2 Neoplasm Metastasis 2 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma 1

Interventions

Gemcitabine 34 Cisplatin 20 Oxaliplatin 14 pembrolizumab 11 Capecitabine 11 Fluorouracil 8 Leucovorin 7 Radiofrequency Ablation 6 lenvatinib 5 Panitumumab 5 Bevacizumab 5 Albumin-Bound Paclitaxel 5 durvalumab 4 Nivolumab 4 Irinotecan 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 Taxes 3 Injections 3 Hepatectomy 3 Drug Therapy 3 trametinib 2 spartalizumab 2 sintilimab 2 pemigatinib 2 derazantinib 2 budigalimab 2 atezolizumab 2 apatinib 2 Stents 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡